Could a breast cancer drug help cystic fibrosis patients?
NCT ID NCT07289035
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tests the safety of tamoxifen citrate in 35 adults with cystic fibrosis who cannot take current CFTR modulator drugs. Participants will take tamoxifen daily for 6 months and visit the clinic every 28 days. The main goal is to see what side effects occur and whether the drug is tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS - COMPLETE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UOC Fibrosi Cistica - AOUI Verona
Verona, Veneto, 37126, Italy
Conditions
Explore the condition pages connected to this study.